Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of NRF2 in Ovarian Cancer
Giovanni Tossetta, Sonia Fantone, Eva Montanari, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 663-663
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 105
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 76
Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway
Giovanni Tossetta, Daniela Marzioni
Pharmacological Research (2022) Vol. 183, pp. 106365-106365
Closed Access | Times Cited: 75
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
Giovanni Tossetta, Sonia Fantone, Federica Piani, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1545-1545
Open Access | Times Cited: 69
Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers
Giovanni Tossetta, Daniela Marzioni
European Journal of Pharmacology (2023) Vol. 941, pp. 175503-175503
Closed Access | Times Cited: 61
Reactive oxygen species and ovarian diseases: Antioxidant strategies
Junzhi Liang, Yingzhuo Gao, Ziyi Feng, et al.
Redox Biology (2023) Vol. 62, pp. 102659-102659
Open Access | Times Cited: 59
The Role of NQO1 in Ovarian Cancer
Giovanni Tossetta, Sonia Fantone, Gaia Goteri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7839-7839
Open Access | Times Cited: 55
Role of SLC7A11/xCT in Ovarian Cancer
Sonia Fantone, Federica Piani, Fabiola Olivieri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 587-587
Open Access | Times Cited: 46
Role of CD93 in Health and Disease
Giovanni Tossetta, Federica Piani, Claudio Borghi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1778-1778
Open Access | Times Cited: 43
Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3037-3037
Open Access | Times Cited: 37
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7
Open Access | Times Cited: 36
Melatonin-Derived Carbon Dots with Free Radical Scavenging Property for Effective Periodontitis Treatment via the Nrf2/HO-1 Pathway
Xirui Xin, Junjun Liu, Xinchan Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8307-8324
Closed Access | Times Cited: 24
Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
Giovanni Tossetta
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12893-12893
Open Access | Times Cited: 51
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3207-3207
Open Access | Times Cited: 30
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Lin Li, Qing Wu, Feifei Lu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 30
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants
Yanru Long, Houhui Shi, Jiatian Ye, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 114-114
Open Access
Re-Sensitization of Resistant Ovarian Cancer SKOV3/CDDP Cells to Cisplatin by Curcumin Pre-Treatment
Aseel Ali Hasan, Elena Kalinina, Dmitry D. Zhdanov, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 799-799
Open Access
NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer
Daniela Marzioni, Roberta Mazzucchelli, Sonia Fantone, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 1, pp. 873-881
Closed Access | Times Cited: 35
Ovarian Cancer and Glutamine Metabolism
Zacharias Fasoulakis, Antonios Koutras, Thomas Ntounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5041-5041
Open Access | Times Cited: 17
Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance
Jiawen Chen, Sibao Chen, Guoqing Chen
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 709-27
Open Access | Times Cited: 16
NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway
Xiaohui Sun, Mingxin Dong, Jiale Li, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 681-698
Open Access | Times Cited: 5
Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications
İlhan Yaylım, Melek Aru, Ammad Ahmad Farooqı, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Adjuvant Properties of Caffeic Acid in Cancer Treatment
Nicole Cortez, Cecilia Villegas, Viviana Burgos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7631-7631
Open Access | Times Cited: 4
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
Johannes F. Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2543-2543
Open Access | Times Cited: 24
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
Chih-Chang Chao, Chuen‐Lin Huang, Jing‐Jy Cheng, et al.
Redox Biology (2022) Vol. 58, pp. 102534-102534
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top